Miller, Paul D <br/><br/>
Response to the Letter: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid.  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  09 2016 
 - L91-2 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't; Comment 
<br/><br/><label>ISSN: </label>1945-7197 
<br/><br/><label>Standard No.: </label>10.1210/jc.2016-2902  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Bone Density<br/>Bone Density Conservation Agents<br/>Denosumab<br/>Diphosphonates<br/>Humans<br/>Imidazoles<br/>Minerals<br/>Zoledronic Acid